Preterm feeding recommendations are achievable in large-scale research studies by Leila Cheikh Ismail et al.
RESEARCH ARTICLE Open Access
Preterm feeding recommendations are
achievable in large-scale research studies
Leila Cheikh Ismail1,12*, Francesca Giuliani2, Bashir A. Bhat3, Deborah Bishop1, Aris T. Papageorghiou1,
Roseline Ochieng4, Fabien Puglia1, Douglas G. Altman5, Michael Maia-Schlüssel1, Julia A. Noble6, Enrico Bertino2,
Michael G. Gravett7, Manorama Purwar8, Lui Yajing9, Denise Mota10, Eric Ohuma1,5, Ann Lambert1,
Stephen H. Kennedy1, Zulfiqar A. Bhutta11, José Villar1 and for the International Fetal and Newborn Growth
Consortium for the 21st Century (INTERGROWTH-21st)
Abstract
Background: The INTERGROWTH-21st Project aimed to produce international, prescriptive, postnatal growth
standards for preterm infants born to healthy, well-nourished mothers receiving adequate antenatal care. There is
little information available regarding optimal postnatal growth among uncomplicated preterm newborns. We
describe how the preterm infants contributing to the standards followed evidence-based feeding
recommendations.
Methods: In the Fetal Growth Longitudinal Study (FGLS), a component of the INTERGROWTH-21st Project, fetal
growth was monitored by ultrasound from <14 weeks’ gestation until birth in pregnancies at low risk of adverse
outcomes. All preterms (≥26+0 and <37+0 weeks’ gestation) were followed up during infancy. Internationally-
accepted feeding recommendations for preterms, agreed by the INTERGROWTH-21st Neonatal Group, were
implemented at each study site. Standardised questionnaires served to record information on their feeding
practices.
Results: Feeding data were collected from 201 eligible preterms. The median (interquartile range, IQR) gestational age
at birth was 36.0 (35.0 – 36.6) weeks. The prevalence of any breastfeeding was 82 % within 72 h of birth, 96 % at
2 weeks, 82 % at 4 months and 70 % at 8 months postnatal age. The figures for exclusive breastfeeding were 51 %
within 72 h of birth, 72 % at hospital discharge, 49 % at 4 months, 38 % at 5 months and 12 % at 6 months.
Complementary foods were introduced at a median (IQR) postnatal age of 6.0 (5.1 – 6.8) months.
Conclusion: Most preterms were exclusively breastfed upon hospital discharge, and breastfeeding remained a
substantial source of nutrition throughout the study. Recommendations, centred on breastfeeding, were adequately
followed within the expected variation of such diverse settings.
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Background
INTERGROWTH-21st is a multi-country project to
develop international, prescriptive standards for fetal
growth, newborn size and preterm postnatal growth [1],
to complement the existing WHO Child Growth Stan-
dards [2, 3]. Such standards describe how individuals
should grow, as opposed to reference charts that de-
scribe how individuals have grown at particular times
and locations [4]. The aim of the Postnatal Preterm Follow-
up Study (PPFS), a component of the INTERGROWTH-
21st Project was to construct prescriptive standards to
monitor the postnatal growth of preterm infants following
our a priori conceptual framework [4]. Using a similar ap-
proach to the WHO Multicentre Growth Reference Study
(MGRS) [2, 3], we studied a cohort of uncomplicated, pre-
term infants born to healthy, well-nourished women from
geographically diverse populations, who received adequate
antenatal care and were at low risk of adverse maternal and
perinatal outcomes, and who were not exposed to any
known non-microbiological contamination or toxic sub-
stances [5].
Preterm infants are a heterogeneous group, varying by
gestational age at birth and the severity of their comor-
bidities, many of which are associated with being born at
a very early gestational age and growth restricted [6].
Some of the comorbidities are also probably associated
with immature gastrointestinal function, resulting in an
imbalance between rapid growth, nutrient supply and
the adequacy of the metabolic response, occurring
during the unplanned transition from trans-placental
nutrition to oral feeding [7, 8].
There is controversy, both conceptually and at a prac-
tical level, about how best to feed preterms; hence,
feeding practices vary among and within countries [9].
Some practices have been proposed, which should sup-
port a tissue accretion rate matching that of normal
intrauterine growth. This approach assumes that the
growth rate of a fetus of a comparable gestational age is
desirable for the postnatal growth, development and
long-term health of a preterm. However, such a pattern
is seldom attained in preterm neonates, who almost al-
ways show a postnatal cumulative nutritional deficit
and so-called ‘extrauterine growth restriction’ [10].
Feeding guidelines for term infants are based on the
substantial benefits of breast milk, e.g. decreased rates
of infection and mortality, and better long-term out-
comes, including improved neurocognitive and cardio-
vascular development. There is increasing evidence that
there are also important benefits to be gained from giv-
ing the mother’s milk to sick and preterm infants in
neonatal intensive care units [11]. However, their nutri-
tional needs are different from those of term infants
and should be evaluated carefully, especially bearing in
mind the need to fortify human milk [11].
Therefore, in developing the preterm prescriptive
growth standards, it was essential to ensure that the rec-
ommended feeding practices for optimal postnatal
growth in preterms were implemented, including the
provision of supplements and complementary foods
when necessary. In this paper, we describe the breast-
feeding and complementary feeding practices of the in-
fants enrolled in PPFS.
Methods
Study design
INTERGROWTH-21st was a population-based project
conducted between 2009 and 2014, in eight urban areas:
the cities of Pelotas, Brazil; Turin, Italy; Muscat, Oman;
Oxford, UK; Seattle, USA; Shunyi County, a suburban dis-
trict of the Beijing municipality, China; the central area of
the city of Nagpur (Central Nagpur), Maharashtra, India;
and the Parklands suburb of Nairobi, Kenya [1].
All singleton, preterm newborns (≥26+0 to <37+0
weeks’ gestation) in the Fetal Growth Longitudinal Study
(FGLS) component of INTERGROWTH-21st, whose
intrauterine growth was monitored by ultrasound, were
eligible for PPFS. The detailed methodology has been
published elsewhere [1]. Briefly, infants contributing to
the standards must have: a) been free of major congenital
malformations and severe neonatal conditions associated
with impaired postnatal growth; b) received standardised,
evidence-based care [12], and c) been exclusively or pre-
dominantly breastfed according to current recommenda-
tions. To achieve this goal, the INTERGROWTH-21st
Neonatal Group developed, before the study commenced,
a set of minimum recommendations for neonatal and
postnatal care, based on current practice and recent publi-
cations (Table 1) [12–15]. Their feeding recommendations
promoted exclusive breastfeeding by the time of hospital
discharge and up to 6 months of age, consistent with the
recommendations of WHO that have been adopted
widely. Food source recommendations were, in order of
preference, breastfeeding or expressed breast milk,
donor human milk, and preterm formula. Guidelines
for the initiation of milk feeding and progression
volumes, and the use of nutritional supplements and
fortifiers were provided [12, 15].
Data collection
Follow-up visits were scheduled 48–72 h after birth,
every 2 weeks (i.e. 2 weeks ± 2 days, 4 ± 3, 6 ± 4, and
8 weeks ± 5 days from birth) during the first 8 weeks
after birth, then every 4 weeks (i.e. 3 months ± 9 days,
4 ± 12, 5 ± 15, 6 ± 18, 7 ± 21, and 8 months ± 24 days
after birth) until 8 months of postnatal age. Standardised
questionnaires, used at each visit, recorded feeding
practices and morbidity (available from www.inter-
growth21.org.uk). Mothers were asked to recall the food
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types consumed, methods of feeding, use of vitamin and
mineral supplements, and dietary intake of their infant in
the 24-h period preceding the visit, using an Infant Food
Recall (IFR) questionnaire. If their diet on that day was
atypical (e.g. due to illness or travelling), mothers were
asked to recall the last typical day. Anthropometric mea-
surements (weight, length and head circumference) were
taken as in WHO MGRS [16].
Variable definitions and classifications
Feeding practices were defined according to WHO indi-
cators [17]. Exclusive breastfeeding refers to exclusive
human breast milk with no other foods or liquids (in-
cluding water), except oral rehydration solution and
drops/syrups of vitamins, minerals or medicines. Pre-
dominantly breastfed refers to breast milk as the main
source of nourishment but additional water or water-
based drinks, such as teas or infusions, fruit juice or rit-
ual fluids, were offered. Partial breastfeeding refers to
some breast milk as well as other foods or food-based
fluids, such as formula milk or weaning foods. Formula
and other liquids refer to predominantly received stand-
ard-, preterm-, high-energy-, soy-based-, hydrolysed-, or
other special- formulas for preterm and low-birth-
weight infants, plus water, fruit or vegetable juice, tea or
sweetened drinks.
Complementary foods included all semi-solid or solid
foods besides milk or formula, except water, fruit or vege-
table juice, tea and sweetened drinks and were categorised
into seven groups: grains, roots and tubers; legumes and
nuts; dairy products; flesh foods; eggs; vitamin A-rich fruits
and vegetables; and other fruits and vegetables.
Data analysis
The mean and standard deviation (SD), or median and
interquartile range (IQR), were used to describe continu-
ous variables, and percentages for categorical variables.
Where appropriate, the infants were categorised accord-
ing to gestational age into early (<34+0 weeks’ gestation)
and late (≥34+0 to <37+0 weeks’ gestation) preterms.
Ethical approval and consent
The INTERGROWTH-21st Project was approved by the
Oxfordshire Research Ethics Committee “C” (reference
08/H0606/139), the research ethics committees of the
individual participating institutions, and the correspond-
ing regional or national health authorities where the pro-
ject was carried out. We obtained institutional consent
to use routinely collected data and women gave oral
consent.
Results
In total, 224 preterms were born in FGLS. Of these, 201
(99 boys and 102 girls) were alive, free of congenital mal-
formations and enrolled in PPFS. The distribution of the
201 preterm newborns across sites was: Brazil = 18 %;
China = 9 %; India = 15 %; Italy = 12 %; Kenya = 15 %;
Oman = 15 %; UK = 11 %, and USA = 5 %. We docu-
mented feeding practices of these infants during their first
8 months after birth.
Most mothers (45.3 %) were aged 25–30 years and
72.6 % were nulliparous; 30.4 % had pregnancy-related
and 19.9 % non-pregnancy-related complications (Table 2).
Of those with pregnancy-related complications, the most
common were pregnancy-induced hypertension (8.5 %),
vaginal bleeding >27 weeks’ gestation (5.5 %), gestational
diabetes (5.0 %), and pre-eclampsia (3.0 %) (data not
shown). At birth, the mean (SD) birthweight was 2,452
(519) g, length 45.6 (2.7) cm, and head circumference 31.7
(1.8) cm (Table 2). The population was mostly composed
of late preterm infants, as the median gestational age (GA)
was 36 weeks (IQR 35.0 - 36.6).
Forty-seven percent of newborns were admitted to an
intensive or special care unit after birth for respiratory
support (10.1 %), surfactant treatment (2.4 %) or tube
Table 1 Evidence-based recommendations used in Preterm
Postnatal Follow-up Study of the INTERGROWTH-21st Project
The overall goal of this guideline is to promote exclusive breastfeeding
of the preterm infant by the time of hospital discharge.
What to feed, in order
of preference
1. Mother’s own milk from the breast.
2. Mother’s expressed breast milk.
3. Donor human milk, if available.
4. Preterm formula.
How to feed Orogastric feeding is preferred over a
nasogastric tube, especially if the infant
has increased work of breathing.
Continuous, over-bolus feeds not
recommended, no strong evidence for this.
Infants should be encouraged to suck at the
breast once sucking behavior is observed.
Feed volume Start with approximately 80 ml/kg per day.
Increase by 10–20 ml/kg per day to a
maximum of approximately 160–180 ml/kg
per day by the end of the first week of life.
Feed progression Most infants >32 weeks’ gestation will
tolerate maintenance enteral feeds from the
first day of life.
Infants <32 weeks’ gestation should be
introduced to small amounts of trophic feeds
(10–24 ml/kg per day) on first day of life.
Infants >32 weeks’ gestation are likely to
tolerate faster increases in volume.
Human milk
supplementation
Vitamin D: 400 IU per day.
Phosphorus & calcium:
some evidence for reducing metabolic
bone disease in infants weighing <1,500 g.Iron:
2 mg/kg per day, start by 8 weeks of age.
Multi-component fortifiers: Associated with
short-term increases in weight gain, linear
growth and head growth. No evidence for l
ong-term benefits or adverse effects.
Duration of exclusive
breastfeeding
6 months in low birth weight infants
accompanied by iron supplementation.
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feeding/parenteral nutrition (34.3 %). The most common
neonatal problems were hyperbilirubinemia (22.9 %), re-
spiratory distress (10.4 %), lack of oral feeding for >24 h
(11.9 %), and transient tachypnea (14.9 %). The median
(IQR) length of stay at special care units was 4.0 (2–8)
days; three (1.5 %) preterms stayed in hospital for
≥60 days (data not shown). As expected, most of the
postnatal morbidities known to be related to severe
Table 2 Neonatal and maternal characteristics
Variables N (N = 201) Value
Maternal







2 or more 14 7.0
Pregnancy-related complications (%) 61 30.4
Non-pregnancy-related complications (%) 40 19.9
Neonatal
Girls (%) 102 50.7
Gestational age at birth (weeks) (median, IQR) 201 36.0 (35.0 – 36.6)
Early preterm, <34 weeks (%) 28 13.9
Late preterm, ≥34 weeks and <37 weeks (%) 173 86.1
Birthweight (g)a (mean ± SD)a 200 2452 (±519)
Head circumference (cm)a (mean ± SD)a 193 31.7 (±1.8)
Length (cm)a (mean ± SD)a 191 45.6 (±2.7)
Apgar at 5 min (mean ± SD)a 200 9.2 (±0.9)
Days until hospital discharge (median, IQR) 201 4.0 (2.0 – 8.0)
Intensive/special care unit admission > 1 day (%) 82 40.7
Tube feeding or parenteral nutrition (%) 44 21.9
Hyperbilirubinemia (%) 46 22.9
Respiratory distress syndrome (%) 21 10.4
No oral feeds for >24 h but <7 days (%) 24 11.9
Transient tachypnea of the newborn (%) 30 14.9
Hypoglycemia (%) 16 8.0
Apnea of prematurity (%) 14 7.0
Anaemia requiring transfusion (%) 2 1.0
Patent ductus arteriosus requiring pharmacological treatment (%) 4 2.0
Hypotension requiring inotropic treatment or steroids (%) 3 1.5
Bronchopulmonary dysplasia (%)b 1 0.5
Other infection (%) 2 1.0
Meconium aspiration with respiratory distress (%) 1 0.5
Intraventricular hemorrhage grade I-II (%) 2 1.0
Retinopathy of prematurity (%) 1 0.5
Pneumonia/Bronchiolitis (%) 5 2.5
Stoppage of enteral feeding for >3 consecutive days (%) 2 1.0
a Missing data
b With normal growth and development
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prematurity (e.g. bronchopulmonary dysplasia, apnea of
prematurity, retinopathy of prematurity) were observed
in the very preterm infants (GA <32 weeks)
Within the first 72 h after birth, oral feeding was initi-
ated in 94 % of the infants. The percentage of infants
who received any breastfeeding was 81.8 % within 72 h
of birth, 96.4 % at 2 weeks of age, 93.5 % at 8 weeks and
82 % at 4 months (Fig. 1). Exclusive breastfeeding in-
creased from 51.1 % at 72 h after birth (Fig. 1) to 72.1 %
by hospital discharge, (late preterms = 75.7 % and early
preterms = 50.0 %, data not shown), with a further
16.9 % partially breastfed at hospital discharge (late pre-
terms = 15.0 % and early preterms = 28.6 %, data not
shown) (Fig. 2). The rate of exclusive breastfeeding con-
tinued to increase to 64.1 % at 2 weeks, and was sus-
tained until 3 months of postnatal age in 55.5 % of the
cohort (57.6 and 44.0 % of late and early preterms, re-
spectively; data not shown). At 4 weeks, 31.1 % of in-
fants were fed with breast milk and other milk/formula
only, decreasing to 26.0 % at 8 weeks, 31.7 % at
3 months, 26.7 % at 4 months and 10.3 % at 6 months
(Fig. 1). Exclusive breastfeeding gradually diminished be-
tween 5 and 8 months from 36.8 to 0.8 % and 41.7 to
4.6 %, in late and early preterms, respectively (data not
shown), while the consumption of semi-solid and solid
foods increased from 32.3 % at 5 months to 96.5 % at
8 months (37.2 to 97.5 %, and 4.17 to 90.9 %, in late and
early preterms, respectively) (Fig. 2). High rates of any
breastfeeding continued with 73.7 % still being breastfed
at 6 months, and 70.4 % (early preterms = 70.8 % and
late preterms = 68.2 %, data not shown) still receiving
breast milk at 8 months of age (Fig. 2).
Grains, roots and tubers were consumed by 19.3 % of
preterms at 5 months, 51.1 % at 6 months and 90.1 % at
8 months of age (Fig. 3). By 5 months, vitamin A-rich
fruits and vegetables and other fruits and vegetables were
being consumed by 12.4 and 16.8 %, respectively. These
two food groups were not offered as frequently as grains,
roots and tubers, but were given to 61.3 and 72.5 % of
infants, respectively, by 8 months. Flesh foods, eggs, and
legumes and nuts were offered to 36.8, 7.9, and 13.2 % of
infants at 7 months of age, respectively. By 8 months,
flesh foods were given to 51.4 % of preterms, while the
consumption of eggs, and legumes and nuts remained
low (14.1 and 19.7 %, respectively).
Iron supplements were routinely given to preterm in-
fants at most sites in hospital and after discharge, except
Oxford where, typically, only infants <35 weeks’ gesta-
tion received supplements. Most sites provided Vitamin
D supplements for infants after discharge but in the par-
ticipating Nairobi hospitals, vitamin D was only given to
selected preterms, and the practice was not standard in
Oman. Vitamin K was given at birth to preterm babies
at all sites, and most gave multivitamins during and after
the hospital stay. Participating hospitals in Brazil gave
multivitamins to selected preterms only; standard prac-
tice in China was Vitamin A supplementation in hospital
and after discharge.
The patterns of longitudinal growth in this cohort for
length were very similar to those of the WHO Child
Growth Standards for term neonates [2] during the first
months of life, but weight and head circumference dif-
fered from the WHO standards until 64 weeks’ post-
menstrual age [18].
Discussion
One of the aims of the INTERGROWTH-21st Project was
to produce, for the first time, international standards for
Fig. 1 Feeding practices of the preterm infants at each follow-up point. Parenteral nutrition or complementary foods refers to preterm infants
receiving parenteral nutrition support during their first 72 h, and infants receiving complementary foods only thereafter. Formula and other liquids
refers to exclusive formula feeding during their first 72 h and formula with other liquids thereafter
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postnatal growth of preterm infants by gestational age,
conforming to the prescriptive approach used in WHO
MGRS. Healthy, well-nourished women with minimal
constraints on fetal growth were studied prospectively,
resulting in a relatively homogenous and ‘healthy’ popula-
tion (according to gestational age) of preterm infants. To
support the development of the standards, descriptive data
were collected to document the degree to which feeding
guidelines for adequate postnatal growth were followed.
The participating neonatal teams agreed to follow a
set of recommended feeding practices based on the in-
creasing evidence of the short- and long-term benefits of
breastfeeding for preterm infants. This included guide-
lines on supplementation and the introduction of com-
plementary foods.
In this cohort, nearly half the preterm infants were ex-
clusively or predominantly breastfed until 4 months of
age, and over two-thirds were still being breastfed at
8 months of age. The rates of exclusive or predominant
breastfeeding were lower in this study than in WHO
MGRS (MGRS – approximately 80 and 63 %; PPFS –
65.3 and 56.5 % at 4 weeks and 3 months, respectively)
[19]. These results are not unexpected as breastfeeding
rates are generally lower in preterm compared to term
infants [9, 20–22], and establishing and maintaining
breastfeeding in preterms requires considerable support.
Factors that may impact upon the ability of preterms to
breastfeed are clinical conditions related to prematurity,
extended hospitalization, increased sleepiness and ma-
ternal illness. Other obstacles may include reduced
muscular strength affecting latching, suckling and swal-
lowing. The infant may also be discharged before lacta-
tion is fully established, so breastfeeding difficulties
cannot be addressed by healthcare professionals. We
emphasised these issues across the study sites, suggest-
ing strategies to help mothers overcome these barriers.
Fig. 2 Proportion of preterm infants exclusively breastfed, partially breastfed and receiving solid or semi-solid foods, at hospital discharge and
each follow-up point
Fig. 3 Proportion of preterm infants consuming solid or semi-solid food groups, between 3 and 8 months of follow-up
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However, moving from the context of a research project
to general practice will, realistically, be far more
challenging.
It has been suggested that, wherever possible, pre-
term infants should be introduced to solid foods be-
tween 5 and 8 months of age to ensure that the
appropriate transition period is not missed, and to
encourage the development of feeding skills [23].
Healthy, late preterms, born ≥34 weeks’ gestation,
may be introduced to solid foods using the same
guidelines as term infants. The mean age at which
complementary foods were introduced in PPFS was
6 months; not much later than reported for term in-
fants (5.4 months) enrolled in a similar context, who
achieved the recommended feeding criteria in WHO
MGRS [24]. Of the complementary food groups, the
grains, roots and tubers group was the most consist-
ently offered, also similar to WHO MGRS.
Both the American Academy of Pediatrics and
European Society of Paediatric Gastroenterology,
Hepatology and Nutrition recommend preterm infants
receive an iron supplement after hospital discharge
[25, 26]. Unlike exclusively breastfed term infants,
who can usually maintain their iron levels until ap-
proximately 6 months of age, breastfed preterm
infants should receive regular iron supplementation, 2–
4 mg/kg/day, from hospital discharge until approximately
6 to 12 months of age [25–27]. Such recommendations
were fully implemented at all INTERGROWTH-21st sites.
There is some evidence to suggest that low birth weight
infants and preterms <32 weeks’ gestation may benefit
from multivitamins and vitamin D supplementation
[14]; nearly all our sites provided these supplements
after hospital discharge, and vitamin K was given as
standard at birth.
PPFS was designed to construct prescriptive standards
from a population of preterm infants with the best po-
tential for healthy growth and development, if supported
by adequate nutrition and clinical care. Exclusive breast-
feeding was established in most PPFS infants by hospital
discharge and breastfeeding remained an important
source of nutrition for these infants throughout the
study. This was consistent with the main goal of the
INTERGROWTH-21st Neonatal Group feeding guide-
lines [12], which were based on the most current evi-
dence to promote optimal growth at the population level
for uncomplicated preterm infants [14].
By 64 weeks’ postmenstrual age, the 50th centiles of
our cohort’s weights, lengths and head circumferences
merged with those of the WHO Child Growth Standards
[2], which indicates that preterm infants without severe
postnatal complications, who are predominantly breast-
fed and receiving adequate postnatal care, progressively
recuperate in early postnatal life [18].
Conclusions
There is little high-quality information available regard-
ing the most appropriate patterns of postnatal growth
for the optimal development and long-term health of
preterm infants. Current evidence advocates breastfeed-
ing with appropriate supplementation as the best way to
support the growth and development of healthy preterm
infants. When conducting postnatal growth research, it
is essential to document feeding practices and the extent
to which they adhered to the best available evidence.
Uncomplicated, preterm infants can follow evidence-
based feeding recommendations centered on breastfeed-
ing. When assessed against the WHO Child Growth
Standards for 6 month old infants, adequate growth is
achievable for babies born preterm with appropriate nu-
trition and clinical care.
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